The Role of [
[18F]F-choline PET/CT
conventional imaging
outcome
prostate cancer
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
01 Oct 2022
01 Oct 2022
Historique:
received:
31
08
2022
revised:
22
09
2022
accepted:
28
09
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
28
10
2022
Statut:
epublish
Résumé
Initial staging of prostate cancer (PCa) is usually performed with conventional imaging (CI), involving computed tomography (CT) and bone scanning (BS). The aim of this study was to analyze the role of [
Identifiants
pubmed: 36289724
pii: biomedicines10102463
doi: 10.3390/biomedicines10102463
pmc: PMC9598779
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Urol Oncol. 2015 Mar;33(3):109.e23-31
pubmed: 25655681
Clin Prostate Cancer. 2005 Sep;4(2):109-12
pubmed: 16197611
Skeletal Radiol. 2014 Nov;43(11):1503-13
pubmed: 24841276
Q J Nucl Med Mol Imaging. 2019 Mar;63(1):19-28
pubmed: 29383928
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Diagnostics (Basel). 2022 May 24;12(6):
pubmed: 35741119
Eur Urol. 2011 Jul;60(1):125-30
pubmed: 21292388
Ann Nucl Med. 2020 Dec;34(12):932-941
pubmed: 32975741
Nat Rev Cancer. 2011 Nov 17;11(12):835-48
pubmed: 22089420
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):941-949
pubmed: 28138747
BJU Int. 2012 Dec;110(11):1666-71
pubmed: 22520686
Lancet. 2020 Apr 11;395(10231):1208-1216
pubmed: 32209449
Scand J Urol. 2015;49(5):345-53
pubmed: 25649494
Eur J Nucl Med Mol Imaging. 2022 Jul;49(9):3257-3268
pubmed: 35217883
Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):694-701
pubmed: 24297503
Int J Mol Sci. 2022 Aug 14;23(16):
pubmed: 36012384
Radiol Med. 2018 Dec;123(12):952-965
pubmed: 30116970
Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1247-56
pubmed: 25759164
AJR Am J Roentgenol. 2018 Mar;210(3):635-640
pubmed: 29323548
Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1219-1228
pubmed: 33074376
Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1276-83
pubmed: 25808631
Nat Rev Urol. 2015 Sep;12(9):510-8
pubmed: 26260884
Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):509-520
pubmed: 32789599
Sci Rep. 2018 Mar 9;8(1):4254
pubmed: 29523813
Curr Opin Urol. 2020 Sep;30(5):628-634
pubmed: 32701720
Lancet Oncol. 2019 Sep;20(9):1286-1294
pubmed: 31375469
Contrast Media Mol Imaging. 2018 Nov 5;2018:8945130
pubmed: 30532664
Insights Imaging. 2022 Apr 15;13(1):75
pubmed: 35426518
Curr Med Imaging. 2022 Mar 29;:
pubmed: 35352652
Clin Radiol. 2008 Apr;63(4):387-95
pubmed: 18325358
Urol Oncol. 2020 Jan;38(1):2.e1-2.e9
pubmed: 31447087
Clin Transl Imaging. 2022 Jul 28;:1-9
pubmed: 35919380
Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3917-3928
pubmed: 35435496
Clin Genitourin Cancer. 2018 Aug;16(4):305-312.e1
pubmed: 29859737
Clin Transl Radiat Oncol. 2021 Jul 27;30:71-77
pubmed: 34409175
Radiology. 2010 Mar;254(3):925-33
pubmed: 20177103